60 Day Window for Clinical Trial Approval Official, says 乔治临床( George Clinical ), a leading Asia-Pacific CRO.

通过 George Clinical
发布于：行业新闻

9 AUGUST, 2018 – (BEIJING) In another positive development in China’s rapidly evolving regulatory environment The China National Drug Administration (CNDA) has introduced a 60-day window […]

了解更多

2018年8月15日

China’s dynamism requires a nimble CRO with extensive research networks

通过 George Clinical
Research

China’s meteoric growth over the past twenty years (or so) has seen it go from strength to strength, particularly in the clinical trials sector. As the clinical trial market of the world’s mos […]

了解更多

2016年12月15日

customerservice@georgeclinical.com

Join Our Mailing List

I wish to subscribe to George Clinical communications.

required

Yes

在您的网络中添加乔治临床( George Clinical )

60 Day Window for Clinical Trial Approval Official, says 乔治临床( George Clinical ), a leading Asia-Pacific CRO.

60 Day Window for Clinical Trial Approval Official, says 乔治临床( George Clinical ), a leading Asia-Pacific CRO.

China’s dynamism requires a nimble CRO with extensive research networks

Navigation